The Therapeutic Potential of Antigen‐Oligonucleotide Conjugates

Abstract: Conjugation of protein antigen with immunostimulatory oligonucleotides creates a potent immunogen that elicits antigen‐specific antibody responses, a Th1‐biased cytokine profile, and CD8 cytotoxic T lymphocyte activity. The wide range of humoral and cellular immune responses induced by these conjugates suggests they can be used to create effective vaccines against infectious pathogens and tumors and to beneficially modulate the immune responses seen in allergic diseases. This review summarizes the available data on the use of antigen‐oligonucleotide conjugates and discusses their potential use for the treatment of infectious, oncologic, and allergic diseases in humans.

[1]  S. Akira,et al.  A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[2]  D. Busch,et al.  Cutting Edge: Toll-Like Receptor 9 Expression Is Not Required for CpG DNA-Aided Cross-Presentation of DNA-Conjugated Antigens but Essential for Cross-Priming of CD8 T Cells1 , 2003, The Journal of Immunology.

[3]  E. Raz.  Immunostimulatory DNA: An Overview , 2002 .

[4]  R. Vabulas,et al.  CpG‐DNA aided cross‐presentation of soluble antigens by dendritic cells , 2002, European journal of immunology.

[5]  D. Klinman,et al.  CpG-ODN—Safety Considerations , 2002 .

[6]  D. Richman,et al.  Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites1 , 2001, The Journal of Immunology.

[7]  K. Shirato,et al.  Novel Roles of CpG Oligodeoxynucleotides as a Leader for the Sampling and Presentation of CpG-Tagged Antigen by Dendritic Cells1 , 2001, The Journal of Immunology.

[8]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[9]  E. Raz,et al.  DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice. , 2000, The Journal of allergy and clinical immunology.

[10]  J. Corbeil,et al.  Conjugation of protein to immunostimulatory DNA results in a rapid, long‐lasting and potent induction of cell‐mediated and humoral immunity , 2000 .

[11]  E. Raz,et al.  Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. , 2000, The Journal of allergy and clinical immunology.

[12]  K. Shirato,et al.  Regulation of Murine Airway Eosinophilia and Th2 Cells by Antigen-Conjugated CpG Oligodeoxynucleotides as a Novel Antigen-Specific Immunomodulator1 , 2000, The Journal of Immunology.

[13]  E. Raz,et al.  Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism , 2000, Nature Biotechnology.

[14]  E. Raz,et al.  Immunostimulatory DNA pre-priming: a novel approach for prolonged Th1-biased immunity. , 1999, Cellular immunology.

[15]  J. Reimann,et al.  Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. , 1999, Journal of immunology.

[16]  E. Raz,et al.  Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. , 1999, International immunology.

[17]  K. Barnhart,et al.  CpG motifs as immune adjuvants. , 1999, Vaccine.

[18]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[19]  F. Chisari,et al.  To kill or to cure: options in host defense against viral infection. , 1996, Current opinion in immunology.

[20]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[22]  R. Zinkernagel,et al.  Immune Defence in Mice Lacking Type I and/or Type II Interferon Receptors , 1995, Immunological reviews.

[23]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[24]  A. Bird,et al.  Functions for DNA methylation in vertebrates. , 1993, Cold Spring Harbor symposia on quantitative biology.

[25]  E. Kuramoto,et al.  Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. , 1992, Journal of immunology.

[26]  E. Kuramoto,et al.  In vitro Augmentation of Natural Killer Cell Activity and Production of Interferon‐α/β and ‐γ with Deoxyribonucleic Acid Fraction from Mycobacterium bovis BCG , 1988, Japanese journal of cancer research : Gann.

[27]  Y. Fujisawa,et al.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. , 1984, Journal of the National Cancer Institute.